RU93055026A - Улучшение, вызываемые бензотиофенами - Google Patents

Улучшение, вызываемые бензотиофенами

Info

Publication number
RU93055026A
RU93055026A RU93055026/04A RU93055026A RU93055026A RU 93055026 A RU93055026 A RU 93055026A RU 93055026/04 A RU93055026/04 A RU 93055026/04A RU 93055026 A RU93055026 A RU 93055026A RU 93055026 A RU93055026 A RU 93055026A
Authority
RU
Russia
Prior art keywords
group
substituted
alkanoyloxy
unsubstituted
benzotiophenes
Prior art date
Application number
RU93055026/04A
Other languages
English (en)
Other versions
RU2123335C1 (ru
Inventor
Джон Блэк Лэрри
Улман Брайант Хенри
Джозеф Куллинан Джордж
Фрэнсис Кауффман Раймонд
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of RU93055026A publication Critical patent/RU93055026A/ru
Application granted granted Critical
Publication of RU2123335C1 publication Critical patent/RU2123335C1/ru

Links

Claims (1)

  1. Применение соединения формулы 1
    Figure 00000001

    где n = 0, 1 или 2; R является окси-группой, метокси-группой, (C1-C7)алканоилокси-группой, (C3-C7)циклоалканоилокси-группой, (C1-C6) алкокси-(C1-C7)алканоилокси-группой, незамещенной или замещенной ароилокси-группой или замещенной или незамещенной ароил- карбоксильной группой; R1 является атомом водорода; окси-группой, атомом галогена, метокси-группой, (C1-C7)алканоилокси-группой, (С3-С7)циклоалканоилокси-группой, (C1-C6)алкокси-(C1-C7)алканоилокси-группой, незамещенной или замещенной ароилокси-группой или замещенной или незамещенной ароилкарбоксильной группой; R2 является гетероциклическим кольцом, выбранным из группы, включающей пирролидиновую группу, пиперидиновую группу или гексаметилениминовую группу; или его фармацевтически приемлемой соли или сольвата, для получения медицинского препарата, используемого для снижения уровня содержания холестерина в сыворотке крови животных.
RU93055026A 1992-12-22 1993-12-13 Средство для снижения содержания холестерина в крови, фармацевтическая композиция RU2123335C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99522292A 1992-12-22 1992-12-22
US07/995222 1992-12-22
US07/995,222 1992-12-22

Publications (2)

Publication Number Publication Date
RU93055026A true RU93055026A (ru) 1997-01-20
RU2123335C1 RU2123335C1 (ru) 1998-12-20

Family

ID=25541537

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93055026A RU2123335C1 (ru) 1992-12-22 1993-12-13 Средство для снижения содержания холестерина в крови, фармацевтическая композиция

Country Status (28)

Country Link
US (1) US5464845A (ru)
EP (2) EP0605193B1 (ru)
JP (1) JP3197129B2 (ru)
KR (1) KR100278946B1 (ru)
CN (1) CN1043608C (ru)
AT (1) ATE233559T1 (ru)
AU (1) AU669235B2 (ru)
BG (1) BG61524B1 (ru)
BR (1) BR9305182A (ru)
CA (1) CA2112017C (ru)
CZ (1) CZ283863B6 (ru)
DE (1) DE69332735T2 (ru)
DK (1) DK0605193T3 (ru)
ES (1) ES2193142T3 (ru)
HU (1) HU223342B1 (ru)
IL (1) IL108042A (ru)
MY (1) MY109345A (ru)
NO (1) NO304924B1 (ru)
NZ (1) NZ250486A (ru)
PH (1) PH30430A (ru)
PL (1) PL177349B1 (ru)
RO (1) RO113806B1 (ru)
RU (1) RU2123335C1 (ru)
SG (1) SG52696A1 (ru)
SK (1) SK279271B6 (ru)
TW (1) TW383306B (ru)
YU (1) YU48918B (ru)
ZA (1) ZA939427B (ru)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
USRE39049E1 (en) 1992-07-28 2006-03-28 Eli Lilly And Company Methods for inhibiting bone loss
USRE38968E1 (en) 1992-07-28 2006-02-07 Eli Lilly And Company Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US6197789B1 (en) * 1995-06-07 2001-03-06 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
US5482950A (en) * 1993-10-15 1996-01-09 Eli Lilly And Company Methods for lowering serum cholesterol
US6489355B2 (en) * 1993-12-01 2002-12-03 Eli Lilly And Company Methods of inhibiting the effects of amyloidogenic proteins
RU2135176C1 (ru) * 1993-12-14 1999-08-27 Эли Лилли Энд Компани Водорастворенный комплекс включения соединений бензотиофена с водорастворимым циклодекстрином, способ его получения и фармацевтическая композиция
US5441966A (en) * 1993-12-21 1995-08-15 Eli Lilly And Company Methods of inhibiting Turner's syndrome
ES2215270T3 (es) * 1993-12-21 2004-10-01 Eli Lilly And Company Inhibicion de productos terminales de glicosilacion avanzada.
US6417198B1 (en) 1993-12-21 2002-07-09 Eli Lilly And Company Methods of inhibiting CNS problems in post-menopausal women
US5478847A (en) 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
CO4410191A1 (es) * 1994-09-19 1997-01-09 Lilly Co Eli SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS
US5629425A (en) * 1994-09-19 1997-05-13 Eli Lilly And Company Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiophene
US6562862B1 (en) 1994-10-20 2003-05-13 Eli Lilly And Company Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
WO1996012489A1 (en) * 1994-10-20 1996-05-02 Eli Lilly And Company Bicyclic neuropeptide y receptor antagonists
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
US5484808A (en) * 1995-02-09 1996-01-16 Eli Lilly And Company Methods of inhibiting cell-cell adhesion
EP0738725A3 (en) * 1995-04-21 1997-03-05 Lilly Co Eli Benzothiophenes with basic side chains
US5731328A (en) * 1995-10-10 1998-03-24 Eli Lilly And Company Methods of inhibiting plasminogen activator inhibitor 1
US5726168A (en) * 1995-10-12 1998-03-10 Eli Lilly And Company Lipophilic benzothiophenes
TW442286B (en) * 1996-02-28 2001-06-23 Pfizer New therapeutic uses of estrogen agonists
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
IL120266A (en) * 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
EP0801066A1 (en) * 1996-03-12 1997-10-15 Eli Lilly And Company Heterocyclic substituted benzothiophenes and pharmaceutical compositions
US6008377A (en) * 1996-03-19 1999-12-28 Eli Lilly And Company Synthesis of 3-[4-(2-aminoethoxy)-benzoyl]-2-aryl-6-hydroxy-benzo[B]thiophenes
US6458811B1 (en) 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
US5811437A (en) * 1996-05-21 1998-09-22 Eli Lilly And Company Methods of increasing nitric oxide synthesis
US5747509A (en) * 1996-06-03 1998-05-05 Schering Aktiengesellschaft Method for lowering plasma levels of lipoprotein(a)
CA2206752A1 (en) * 1996-07-02 1998-01-02 George Joseph Cullinan Benzothiophene compounds, intermediates, processes, and methods of use
US5980938A (en) * 1996-07-15 1999-11-09 Eli Lilly And Company Effect of compounds that suppress induction of plasminogen activator inhibitor 1 (PAI-1)
CA2214072C (en) * 1996-08-29 2006-11-14 Eli Lilly And Company Benzo [b] thiophene compounds, intermediates, processes, compositions, and methods
US5773432A (en) * 1996-10-30 1998-06-30 Schering Aktiengesellschaft Method for lowering plasma levels of lipoprotein(a)
UA59384C2 (ru) * 1996-12-20 2003-09-15 Пфайзер, Інк. Предотвращение потери костной массы и ее восстановление с помощью агонистов простагландина
WO1998048792A1 (en) * 1997-04-30 1998-11-05 Eli Lilly And Company A REGIOSELECTIVE ALKYLATION PROCESS FOR PREPARING SUBSTITUTED BENZO[b]THIOPHENES
HUP0003187A3 (en) * 1997-04-30 2002-04-29 Lilly Co Eli Substituted benzothiophenes and process for preparing them
CA2287920A1 (en) * 1997-04-30 1998-11-05 Eli Lilly And Company Intermediates and a process for preparing benzo¬b|thiophenes
CA2231013A1 (en) * 1997-04-30 1998-10-30 Eli Lilly And Company Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceuticals
JP2001523253A (ja) * 1997-04-30 2001-11-20 イーライ・リリー・アンド・カンパニー ベンゾ［ｂ］チオフェン類の製造のための中間体および方法
CA2236254A1 (en) * 1997-04-30 1998-10-30 David Warren Hoard Process for preparing benzo¬b|thiophenes
US6124314A (en) * 1997-10-10 2000-09-26 Pfizer Inc. Osteoporosis compounds
US6096781A (en) 1997-11-14 2000-08-01 Eli Lilly And Company 2-arylbenzo[B]thiophenes useful for the treatment of estrogen deprivation syndrome
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6353003B1 (en) 1998-06-17 2002-03-05 Eli Lilly And Company Method for reducing levels of homocysteine and C-reactive protein
US6087378A (en) * 1998-10-13 2000-07-11 Eli Lilly And Company Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome
OA12117A (en) 1999-12-22 2006-05-04 Pfizer Prod Inc EP4 receptor selective agonists in the treatment of osteoporosis.
ATE346159T1 (de) * 2000-05-08 2006-12-15 Pfizer Prod Inc Enzymatische spaltung von selektiven modulatoren des östrogenrezeptors
US20030216358A1 (en) * 2001-07-05 2003-11-20 Muchmore Douglas Boyer Method for enhancing bone mineral density gain
US20060106010A1 (en) * 2003-05-27 2006-05-18 Black Larry J Methods for inhibiting bone loss
MXPA06006810A (es) * 2003-12-17 2006-08-23 Pfizer Prod Inc Tratamiento de afecciones que se presentan con un nivel bajo de masa osea por terapia de combinacion continua con agonistas selectivos del receptor de prostaglandina ep4 y un estrogeno.
WO2009018165A2 (en) 2007-07-27 2009-02-05 Container Stuffers, Llc Cargo loader
CN101669557B (zh) * 2009-08-20 2012-07-25 杭州六易科技有限公司 一种清热解毒凉茶的制作方法
WO2016021706A1 (ja) * 2014-08-08 2016-02-11 カズマパートナーズ株式会社 縮合複素環化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5441964A (en) * 1993-10-15 1995-08-15 Eli Lilly And Company Methods for inhibiting bone loss using substituted benzothiophene

Similar Documents

Publication Publication Date Title
RU93055026A (ru) Улучшение, вызываемые бензотиофенами
KR940013501A (ko) 혈청 콜레스테롤을 저하시키는데 유용한 벤조티오펜
GR3005315T3 (ru)
RU93004970A (ru) Производные циклоалкилзамещенного глутарамида, их применение, фармацевтическая композиция
RU93005057A (ru) Фармацевтические соединения, производные тиенобензодиазепина, способ их получения, фармкомпозиция и их использование
RU2000124402A (ru) Производные азетидина и пирролидина
FI942457A (fi) Substituoitujen piperidiinien valmistus
ES2001341A6 (es) Un procedimiento de producir un derivado de acido guanidinometilbenzoico.
EG19361A (en) A process for the preparation of piperidine compound having local anaesthetica and analgetic
ES476106A1 (es) Procedimiento para la preparacion de 4-espectinomicilamina.
ES2001094A6 (es) Un procedimiento para la preparacion de un derivado de guanina
RU94013440A (ru) Производные 3-дезоксиолисахаридов, способы их получения и содержащие их фармацевтические композиции
KR920007995A (ko) 벤즈아미드 유도체
PT77309B (de) Isochinolinderivate verfahren zu ihrer herstellung pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
ES8702433A1 (es) Un procedimiento para la preparacion de un compuesto heterociclico sustituido con peptidos.
NZ225528A (en) Benzimidazoles substituted in the 2 position by n(4-n-guanidyl) piperidinyl radicals; preparations thereof; pharmaceutical compositions
ATE18211T1 (de) Chinolinessigsaeuren und diese enthaltende pharmazeutische zubereitungen.
ES455833A1 (es) Procedimientos para la preparacion de derivados de la pipe- ridina.
FI860098A0 (fi) Nya piperazinderivat, foerfarande foer deras framstaellning och farmaceutiska kompositioner som innehaoller dessa foereningar som aktiv ingrediens.
ES8504160A1 (es) Procedimiento para la preparacion de derivados de propan-2-ol
KR900012884A (ko) (+)1-[(3,4,5-트리메톡시)-벤질옥시메틸]-1-페닐-N,N-디메틸-n-프로필아민, 그의 제조방법 및 치료학적 용도
FR2655042B1 (fr) Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ES8304970A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-bencil-4(4-(2-pirimidinilamino)bencil-2,3-dioxopiperazina o sus sales.
JPS5283566A (en) 3-hydroxypiperidine derivatives
MY102089A (en) Antibacterial compounds.